Biochemistry, Genetics and Molecular Biology
Adenomatous Polyposis Coli
9%
Alanine
9%
Amino Acids
10%
Anabolism
9%
Cancer Cell
24%
Carcinogenesis
13%
Cell Death
11%
Chromosome 4q
9%
Circulating Tumor DNA
14%
Colon
18%
CpG Site
13%
DNA Methylation
17%
Dysplasia
14%
Energy Metabolism
9%
Epigenetic Mechanism
20%
Epigenetics
40%
Epigenetics
15%
Epigenomics
15%
Esophagus
55%
Gene Expression
14%
Gene Expression Profiling
9%
Genetic Marker
11%
Genetics
12%
GSTP1
14%
Hepatocyte
28%
Kinase
10%
Liver X Receptor
9%
Loss of Heterozygosity
16%
Messenger RNA
10%
Metalloprotease Inhibitor
10%
Metaplasia
23%
Methylation
100%
Microsatellite Instability
14%
Mouse
17%
Mouse Model
18%
Oxysterol
9%
P16
10%
Phosphotransferase
10%
Polo-Like Kinase
18%
Polymerase Chain Reaction
13%
Precursor
9%
Promoter Region
62%
Room Temperature
9%
RUNX3
9%
Secretion (Process)
18%
Survival Rate
11%
Survivin
9%
Thioredoxin
9%
Tree
10%
Tumor Suppressor Gene
14%
Keyphrases
Abnormal Liver Chemistries
9%
All-cause Mortality
18%
Area Deprivation Index
9%
Barrett
19%
Barrett's Esophagus
37%
Barrett's Metaplasia
18%
Case-cohort Study
9%
Chronic Liver Disease
20%
Clinical Outcomes
13%
Clinical Risk Factors
10%
COVID-19
23%
CpG Sites
10%
Early Events
18%
Endogenous Ouabain
10%
Esophageal Adenocarcinoma
42%
Esophageal Cancer
10%
Esophageal Carcinogenesis
11%
Esophageal Squamous Cell Carcinoma
15%
Gastric Cancer
10%
Hepatitis B Recurrence
18%
Hepatitis B Surface Antigen (HBsAg)
10%
Hepatitis C Virus
10%
Hepatocellular Carcinoma
47%
Hepatocellular Carcinoma Surveillance
16%
Hospitalization
12%
HPP1
11%
Hypermethylation
41%
INTS6
9%
Liver
21%
Liver Transplant Recipients
11%
Liver Transplantation
42%
Loss of Heterozygosity
11%
Mechanical Ventilation
10%
MELD Score
12%
Methylation
38%
Multicenter Research
9%
Neoplastic Progression
29%
Non-alcoholic Fatty Liver Disease (NAFLD)
18%
Normal Esophagus
18%
Obesity
11%
Potential Biomarkers
11%
Pretransplant
10%
Promoter Methylation
24%
Reprimo
14%
Risk Factors
12%
Risk of Progression
11%
Severe Disease
10%
Tachykinin 1
9%
Tumor Suppressor Gene
11%
Wilson Disease
13%
Medicine and Dentistry
All Cause Mortality
13%
Antivirus Agent
11%
Atherosclerosis
9%
Cancer Cell
9%
Cancer Staging
9%
Cancer Therapy
12%
Carcinogenesis
11%
Cholangiocarcinoma
9%
Chronic Liver Disease
18%
Cohort Analysis
10%
Colon Cancer
10%
COVID-19
20%
Disease
25%
Echocardiography
9%
Epigenetic Mechanism
11%
Epigenomics
15%
Fibrosis
11%
Gene Expression
11%
Global Disease Burden
9%
Hazard Ratio
11%
Heart Surgery
9%
Hepatitis C
11%
Hepatitis C Virus
20%
Hepatobiliary Cancer
9%
Hepatocellular Carcinoma
31%
Hepatopulmonary Syndrome
9%
Human Immunodeficiency Virus
18%
Intraarterial Drug Administration
9%
Liver Cancer
18%
Liver Cirrhosis
16%
Liver Disease
25%
Liver Graft
41%
Liver Transplantation
63%
Malignant Neoplasm
31%
microRNA 192
9%
Mitochondrial Fusion
9%
Neoplasm
14%
Nonalcoholic Fatty Liver
28%
Oncogene
9%
Oxysterol
9%
Phosphorus 32
12%
Programmed Cell Death
12%
Radioisotope
13%
Receptor
9%
Serositis
11%
Steatosis
12%
Telomere
9%
Transcatheter Arterial Chemoembolization
9%
Transplantation
33%
Wilson's Disease
28%